Extendicare Inc. (TSE:EXE - Get Free Report) declared a monthly dividend on Friday, May 30th, TickerTech Dividends reports. Shareholders of record on Monday, June 16th will be given a dividend of 0.042 per share on Monday, June 16th. This represents a $0.50 annualized dividend and a yield of 3.51%. The ex-dividend date is Friday, May 30th.
Extendicare Stock Down 0.6%
Shares of EXE stock traded down C$0.08 during trading hours on Friday, reaching C$14.34. 306,964 shares of the company's stock were exchanged, compared to its average volume of 189,131. Extendicare has a 1 year low of C$7.10 and a 1 year high of C$15.24. The stock has a market cap of C$1.20 billion, a PE ratio of 18.28 and a beta of 1.26. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The stock's fifty day moving average price is C$13.67 and its two-hundred day moving average price is C$11.91.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on EXE shares. Cormark upgraded Extendicare to a "moderate buy" rating in a research note on Wednesday, February 19th. BMO Capital Markets boosted their price target on Extendicare from C$13.50 to C$14.50 in a research note on Monday, May 12th. Finally, TD Securities boosted their price target on Extendicare from C$13.00 to C$15.00 and gave the stock a "hold" rating in a research note on Thursday, May 22nd.
View Our Latest Report on EXE
Extendicare Company Profile
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
